Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.08
(-6.25%)
CAD 0.08
(-6.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 31.42 Million CAD | -42.29% |
| 2022 | 54.45 Million CAD | -7.61% |
| 2021 | 58.94 Million CAD | 33.3% |
| 2020 | 44.21 Million CAD | 63.42% |
| 2019 | 27.05 Million CAD | 518.73% |
| 2018 | 4.37 Million CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | -100.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| 2000 | - CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| 1998 | - CAD | 0.0% |
| 1997 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 33.57 Million CAD | 10.57% |
| 2024 Q1 | 30.36 Million CAD | -3.38% |
| 2023 Q3 | 41.52 Million CAD | -18.5% |
| 2023 FY | 31.42 Million CAD | -42.29% |
| 2023 Q2 | 50.94 Million CAD | -3.93% |
| 2023 Q4 | 31.42 Million CAD | -24.3% |
| 2023 Q1 | 53.03 Million CAD | -2.62% |
| 2022 Q3 | 64.14 Million CAD | -0.74% |
| 2022 Q4 | 54.45 Million CAD | -15.11% |
| 2022 FY | 54.45 Million CAD | -7.61% |
| 2022 Q2 | 64.62 Million CAD | 10.92% |
| 2022 Q1 | 58.26 Million CAD | -1.15% |
| 2021 Q1 | 51.87 Million CAD | 17.31% |
| 2021 FY | 58.94 Million CAD | 33.3% |
| 2021 Q4 | 58.94 Million CAD | 10.48% |
| 2021 Q3 | 53.34 Million CAD | 3.97% |
| 2021 Q2 | 51.3 Million CAD | -1.09% |
| 2020 Q1 | 28.94 Million CAD | 6.98% |
| 2020 Q4 | 44.21 Million CAD | 5.49% |
| 2020 Q2 | 32.77 Million CAD | 13.24% |
| 2020 Q3 | 41.91 Million CAD | 27.88% |
| 2020 FY | 44.21 Million CAD | 63.42% |
| 2019 FY | 27.05 Million CAD | 518.73% |
| 2019 Q2 | 17.1 Million CAD | 120.77% |
| 2019 Q3 | 50.59 Million CAD | 195.88% |
| 2019 Q1 | 7.74 Million CAD | 77.13% |
| 2019 Q4 | 27.05 Million CAD | -46.53% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q3 | 3.11 Million CAD | 212.22% |
| 2018 FY | 4.37 Million CAD | 0.0% |
| 2018 Q4 | 4.37 Million CAD | 40.34% |
| 2018 Q2 | 998 Thousand CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q3 | - CAD | 100.0% |
| 2017 Q2 | -156.28 Thousand CAD | -80.01% |
| 2017 Q1 | -86.82 Thousand CAD | 21.17% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | -110.14 Thousand CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | - CAD | -100.0% |
| 2015 Q2 | - CAD | -100.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 100.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q1 | -1009.00 CAD | -866724400332900.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2004 Q2 | - CAD | -100.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2004 FY | - CAD | 0.0% |
| 2004 Q1 | 6627.00 CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| 2003 Q2 | 4196.00 CAD | 0.0% |
| 2003 Q3 | - CAD | -100.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2001 Q2 | - CAD | 0.0% |
| 2001 Q1 | - CAD | 0.0% |
| 2001 Q3 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| 2001 Q4 | - CAD | 0.0% |
| 2000 Q3 | - CAD | 0.0% |
| 2000 FY | - CAD | 0.0% |
| 2000 Q1 | - CAD | 0.0% |
| 2000 Q4 | - CAD | 0.0% |
| 2000 Q2 | - CAD | 0.0% |
| 1999 Q3 | - CAD | 0.0% |
| 1999 Q2 | - CAD | 0.0% |
| 1999 Q4 | - CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| 1999 Q1 | - CAD | 0.0% |
| 1998 FY | - CAD | 0.0% |
| 1998 Q2 | - CAD | 0.0% |
| 1998 Q1 | - CAD | 0.0% |
| 1997 Q4 | - CAD | 0.0% |
| 1997 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aurora Cannabis Inc. | 186.37 Million CAD | 83.137% |
| Avicanna Inc. | 4.54 Million CAD | -591.623% |
| Avant Brands Inc. | 28.93 Million CAD | -8.612% |
| Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 11329.776% |
| Crescita Therapeutics Inc. | 6.12 Million CAD | -413.127% |
| Knight Therapeutics Inc. | 91.83 Million CAD | 65.776% |
| MediPharm Labs Corp. | 9.89 Million CAD | -217.497% |
| OrganiGram Holdings Inc. | 80.95 Million CAD | 61.176% |
| Canopy Growth Corporation | 77.29 Million CAD | 59.337% |
| Willow Biosciences Inc. | 221 Thousand CAD | -14121.267% |